The Neurodevelopmental and Behavioral Phenotyping Screening Protocol
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age6+
SponsorNational Institute of Mental Health (NIMH)
About this trial
The purpose of this protocol is to allow for the careful evaluation of healthy volunteers and individuals with risk for psychiatric disorders or neurodevelopmental disorders, such as autism spectrum disorder for specific protocols at NIH.
Eligibility criteria
Qualifiers
Subjects must be at least 6 weeks of age.
Subjects or their parents must be competent to comprehend the purpose of the screening process and to provide written informed consent. Parents/guardians will sign the consent form, and both minors and adults (depending on results of capacity assessment) will be asked to assent only if it is determined that they understand their role in the study.
Subjects must be willing to undergo an evaluation which may include a psychiatric interview; and medical, neurological, and laboratory examinations (as appropriate, such as renal and liver function tests, serum electrolytes, urinalysis, blood levels of psychotropic drugs, and urine drug screen for the presence of psychoactive drugs and drugs of abuse, as determined on a subject-to-subject basis).
Disqualifiers
None
Trial design
Treatments tested in this trial
- Not listed
Trial groups
5,000 Participants
are grouped into 2 trial groupsSponsors and collaborators
Source ClinicalTrials.gov